Philadelphia-based AI-enabled biotech company Vivodyne announced it closed a $38 million seed funding round led by Khosla Ventures.
CS Ventures, Kairos Ventures, Bison Ventures and MBX Capital also participated in the round.
WHAT IT DOES
Vivodyne is a drug discovery company that uses clinically predictive AI to help identify therapeutic targets and predict a patient's response to a drug by...
Pharmaceutical giant AstraZeneca announced the launch of Evinova, a health technology business focused on bringing digital health solutions already in use globally by the pharma company to clinical research organizations (CROs), trial sponsors and care teams, and patients.
The new company will use established digital technology solutions to streamline clinical trial design and delivery in order...
Cytovale, a medical diagnostics company focused on developing technology that helps diagnose diseases, announced that it has scored $84 million in Series C funding, led by Norwest Venture Partners, with participation from other investors.
WHAT IT DOES
Cytovale offers its diagnostic test, IntelliSep, which received FDA 510(k) clearance last year. The test aims to assist in the early detection of...
Ovia Health, a digital health platform for family care, is set to introduce a fertility and family-building benefit designed to comprehensively support the diverse journeys of employees and health plan members.
Slated for release in January 2024, the offering goes beyond traditional fertility solutions, aiding the entire family-building process, including preconception, pregnancy and postpartum....
GE HealthCare announced a collaboration with Grand Rapids-based cancer treatment center BAMF Health to advance the adoption of theranostics in the U.S.
Theranostics is an emerging technology and a form of precision medicine that fuses imaging technology with therapeutic agents to pinpoint and target cancer cells for destruction.
BAMF Health offers molecular imaging for various types of cancer as...
California-based Carrum Health, a digital marketplace allowing employers to purchase bundled healthcare services, announced in September that it joined the White House-led Cancer Moonshot CancerX initiative, uniting with cross-disciplinary stakeholders to drive innovation in cancer care.
Deirdre Saulet, Carrum's market vice president for oncology, sat down with MobiHealthNews to discuss the...
Akili, the company behind a video game-like prescription digital therapeutic for children with ADHD, reported a rise in third-quarter revenue to $702,000, from $114,000 in the second quarter of this year, which the company attributes to the continued growth of its adult ADHD offering EndeavorOTC.
The company reported total operating expenses of $18.8 million for the third quarter, compared to $15...
Boston-based medical technology company Elucid, which offers AI-enabled imaging analysis software for cardiovascular disease, announced that it has scored $80 million in Series C funding, bringing its total raise to $121 million.
Elevage Medical Technologies led the funding, with additional contributions from other investors.
The company will use the funds to expand the commercialization of its...
Editor's note: This story has been updated with a comment from Philips.
Royal Philips received an additional $44.6 million from the Bill and Melinda Gates Foundation, bringing its total received to $60 million, to support the global deployment of the tech giant's AI-enabled, FDA-cleared Lumify Ultrasound System.
In 2021, Philips received an initial grant of $15.4 million from the Gates...
Direct-to-consumer virtual care company Hims & Hers Health reported 57% year-over-year revenue in the third quarter of this year at $226.7 million, compared to $144.8 million in the same period last year.
Net loss was $7.6 million in Q3 this year, down from $18.8 million in Q3 last year, and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) was $12.3 million,...
